Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery

Colloids and Surfaces B: Biointerfaces

Volumn 135, Issue , 2015, Pages 604-612

  Rahme, Kamil ^a,b,c   Guo, Jianfeng ^d   Holmes, Justin D ^a,b   O'Driscoll, Caitriona M ^d  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c NOTRE DAME UNIVERSITY   (Lebanon)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Gold nanoparticles; Non viral siRNA delivery; PEGylation; Polyethylene glycol dilemma

Indexed keywords

AMINO ACIDS; BIOCOMPATIBILITY; BODY FLUIDS; ESTERS; FIBER OPTIC SENSORS; GOLD; METAL NANOPARTICLES; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENES; PROTEINS; SURFACE ACTIVE AGENTS;

CETYL TRIMETHYL AMMONIUM BROMIDES; GOLD NANOPARTICLES; HYDROXYLAMINE HYDROCHLORIDE; L-CYSTEINE METHYL ESTERS; PEGYLATION; PHYSICOCHEMICAL PROPERTY; SIRNA DELIVERY; SMALL INTERFERING RNA (SIRNA);

RNA;

GOLD NANOPARTICLE; MACROGOL; MECYSTEINE; NUCLEASE; PROTAMINE; SMALL INTERFERING RNA; BIOMATERIAL; CETRIMIDE; CHLORIDE; CYSTEINE; GOLD; HYDROXYLAMINE; LACTIC ACID; MACROGOL DERIVATIVE; METAL NANOPARTICLE; PLASMA PROTEIN; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SURFACTANT;

ARTICLE; BIOCOMPATIBILITY; CHEMICAL MODIFICATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYMATIC DEGRADATION; HUMAN; HUMAN CELL; INTERNALIZATION; MALE; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PEGYLATION; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; SERUM; SURFACE CHARGE; SYNTHESIS; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; GENE TRANSFER; MEDICINAL CHEMISTRY; MOUSE; TUMOR CELL LINE;

ANIMALS; BIOCOMPATIBLE MATERIALS; BLOOD PROTEINS; CELL LINE, TUMOR; CETRIMONIUM COMPOUNDS; CHEMISTRY, PHARMACEUTICAL; CHLORIDES; CYSTEINE; GENE TRANSFER TECHNIQUES; GOLD; HUMANS; HYDROXYLAMINES; LACTIC ACID; METAL NANOPARTICLES; MICE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; RNA, SMALL INTERFERING; SURFACE-ACTIVE AGENTS;

EID: 84955448185     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.08.032     Document Type: Article

References (52)

1. Tuna M., Amos C.I. Cancer Lett. 2013, 340:161-170.
2. Chan E., Prado D.E., Weidhaas J.B. Trends Mol. Med. 2011, 17:235-243.
3. Fitzgerald K.A., Evans J.C., McCarthy J., Guo J., Prencipe M., Kearney M., Watson W.R., O'Driscoll C.M. Expert Opin. Ther. Targets 2014, 18:633-649.
4. Kanasty R., Dorkin J.R., Vegas A., Anderson D. Nat. Mater. 2013, 12:967-977.
5. Dahlman J.E., Barnes C., Khan O.F., Thiriot A., Jhunjunwala S., Shaw T.E., Xing Y.P., Sager H.B., Sahay G., Speciner L., Bader A., Bogorad R.L., Yin H., Racie T., Dong Y.Z., Jiang S., Seedorf D., Dave A., Sandhu K.S., Webber M.J., Novobrantseva T., Ruda V.M., Lytton-Jean A.K.R., Levins C.G., Kalish B., Mudge D.K., Perez M., Abezgauz L., Dutta P., Smith L., Charisse K., Kieran M.W., Fitzgerald K., Nahrendorf M., Danino D., Tuder R.M., von Andrian U.H., Akinc A., Panigrahy D., Schroeder A., Koteliansky V., Langer R., Anderson D.G. Nat. Nanotechnol. 2014, 9:648-655.
6. Guo J.F., Cheng W.P., Gu J.X., Ding C.X., Qu X.Z., Yang Z.Z., O'Driscoll C. Eur. J. Pharm. Sci. 2012, 45:521-532.
7. Guo J.F., Ogier J.R., Desgranges S., Darcy R., O'Driscoll C. Biomaterials 2012, 33:7775-7784.
8. Zhao Y., Zheng C., Zhang L., Chen Y., Ye Y., Zhao M. Colloids Surf. B Biointerfaces 2015, 127:155-163.
9. Kanazawa T., Sugawara K., Tanaka K., Horiuchi S., Takashima Y., Okada H. Eur. J. Pharm. Biopharm. 2012, 81:470-477.
10. Guo J., Cahill M.R., McKenna S.L., O'Driscoll C.M. Biotechnol. Adv. 2014, 32:1396-1409.
11. Xie Y., Qiao H., Su Z., Chen M., Ping Q., Sun M. Biomaterials 2014, 35:7978-7991.
12. Guo J., Evans J.C., O'Driscoll C.M. Trends Mol. Med. 2013, 19:250-261.
13. Bonoiu A.C., Bergey E.J., Ding H., Hu R., Kumar R., Yong K.-T., Prasad P.N., Mahajan S., Picchione K.E., Bhattacharjee A. Nanomedicine 2011, 6:617-630.
14. Jensen S.A., Day E.S., Ko C.H., Hurley L.A., Luciano J.P., Kouri F.M., Merkel T.J., Luthi A.J., Patel P.C., Cutler J.I. Sci. Transl. Med. 2013, 5:ra152-209ra1.
15. Zheng D., Giljohann D.A., Chen D.L., Massich M.D., Wang X.-Q., Iordanov H., Mirkin C.A., Paller A.S. Proc. Natl. Acad. Sci. 2012, 109:11975-11980.
16. Conde J., Rosa J., de la Fuente J.M., Baptista P.V. Biomaterials 2013, 34:2516-2523.
17. Guo J.F., Armstrong M.J., O'Driscoll C.M., Holmes J.D., Rahme K. RSC Adv. 2015, 5:17862-17871.
18. Guo J., Fisher K.A.R., Darcy, Cryan J.F., O'Driscoll C. Mol. Biosyst. 2010, 6:1143-1161.
19. O'Mahony A.M., Godinho B.M., Cryan J.F., O'Driscoll C.M. J. Pharm. Sci. 2013, 102:3469-3484.
20. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanomed. (Lond) 2011, 6:715-728.
21. Rahme K., Nolan M.T., Doody T., McGlacken G.P., Morris M.A., O'Driscoll C., Holmes J.D. RSC Adv. 2013, 3:21016-21024.
22. Brown K.R., Lyon L.A., Fox A.P., Reiss B.D., Natan M.J. Chem. Mater. 2000, 12:314-323.
23. Rahme K., Chen L., Hobbs R.G., Morris M.A., O'Driscoll C., Holmes J.D. RSC Adv. 2013, 3:6085-6094.
24. O'Neill M.J., Guo J.F., Byrne C., Darcy R., O'Driscoll C.M. Int. J. Pharm. 2011, 413:174-183.
25. Unsworth L.D., Tun Z., Sheardown H., Brash J.L. J. Colloid Interface Sci. 2005, 281:112-121.
26. Unsworth L.D., Sheardown H., Brash J.L. Langmuir 2005, 21:1036-1041.
27. Goodman C.M., McCusker C.D., Yilmaz T., Rotello V.M. Bioconjugate Chem. 2004, 15:897-900.
28. Pernodet N., Fang X.H., Sun Y., Bakhtina A., Ramakrishnan A., Sokolov J., Ulman A., Rafailovich M. Small 2006, 2:766-773.
29. Vijayakumar S., Ganesan S. Toxicol. Environ. Chem. 2013, 95:277-287.
30. Schellekens H., Hennink W.E., Brinks V. Pharm. Res. 2013, 30:1729-1734.
31. Elbakry A., Zaky A., Liebl R., Rachel R., Goepferich A., Breunig M. Nano Lett. 2009, 9:2059-2064.
32. Li S.D., Huang L. Mol. Pharm. 2006, 3:579-588.
33. Guo J.F., Bourre L., Soden D.M., O'Sullivan G.C., O'Driscoll C. Biotechnol. Adv. 2011, 29:402-417.
34. Manson J., Kumar D., Meenan B.J., Dixon D. Gold Bull. 2011, 44:99-105.
35. Godinho B.M.D.C., Ogier J.R., Quinlan A., Darcy R., Griffin B.T., Cryan J.F., Driscoll C.M. Int. J. Pharm. 2014, 473:105-112.
36. Nativo P., Prior I.A., Brust M. ACS Nano 2008, 2:1639-1644.
37. Choi C.H., Alabi C.A., Webster P., Davis M.E. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:1235-1240.
38. Verma A., Uzun O., Hu Y.H., Hu Y., Han H.S., Watson N., Chen S.L., Irvine D.J., Stellacci F. Nat. Mater. 2008, 7:588-595.
39. Mishra S., Webster P., Davis M.E. Eur. J. Cell Biol. 2004, 83:97-111.
40. Kouchakzadeh H., Shojaosadati S.A., Tahmasebi F., Shokri F. Int. J. Pharm. 2013, 447:62-69.
41. Cui Y., Xu Q., Chow P.K., Wang D., Wang C.H. Biomaterials 2013, 34:8511-8520.
42. Kim H.A., Nam K., Kim S.W. Biomaterials 2014, 35:7543-7552.
43. Duarte S., Faneca H., Lima M.C. Int. J. Pharm. 2012, 423:365-377.
44. Atkinson S.F., Bettinger T., Seymour L.W., Behr J.P., Ward C.M. J. Biol. Chem. 2001, 276:27930-27935.
45. Zhang X., Yang Z.L., Li W.H., Yang L.M., Weng S.F., Wu J.G. Spectrochim. Acta A 2004, 60:235-240.
46. Tsouris V., Joo M.K., Kim S.H., Kwon I.C., Won Y.Y. Biotechnol. Adv. 2014, 32:1037-1050.
47. Toriyabe N., Hayashi Y., Harashima H. Biomaterials 2013, 34:1337-1343.
48. Lee M.-Y., Park S.-J., Park K., Kim K.S., Lee H., Hahn S.K. ACS Nano 2011, 5:6138-6147.
49. Varkouhi A.K., Scholte M., Storm G., Haisma H.J. J. Control Release 2011, 151:220-228.
50. Lee S.H., Bae K.H., Kim S.H., Lee K.R., Park T.G. Int. J. Pharm. 2008, 364:94-101.
51. Kong W.H., Bae K.H., Jo S.D., Kim J.S., Park T.G. Pharm. Res. 2012, 29:362-374.
52. Guo J., Rahme K., Fitzgerald K.A., Holmes J.D., O'Driscoll C.M. Nano Res. 2015, 10.1007/s12274-015-0829-4.